Format

Send to

Choose Destination
Chem Biol. 2012 Jan 27;19(1):85-98. doi: 10.1016/j.chembiol.2011.12.014.

Lessons from the past and charting the future of marine natural products drug discovery and chemical biology.

Author information

1
Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Science, University of California San Diego, La Jolla, CA 92037, USA. wgerwick@ucsd.edu

Erratum in

  • Chem Biol. 2012 Dec 21;19(12):1631.

Abstract

Marine life forms are an important source of structurally diverse and biologically active secondary metabolites, several of which have inspired the development of new classes of therapeutic agents. These success stories have had to overcome difficulties inherent to natural products-derived drugs, such as adequate sourcing of the agent and issues related to structural complexity. Nevertheless, several marine-derived agents are now approved, most as "first-in-class" drugs, with five of seven appearing in the past few years. Additionally, there is a rich pipeline of clinical and preclinical marine compounds to suggest their continued application in human medicine. Understanding of how these agents are biosynthetically assembled has accelerated in recent years, especially through interdisciplinary approaches, and innovative manipulations and re-engineering of some of these gene clusters are yielding novel agents of enhanced pharmaceutical properties compared with the natural product.

PMID:
22284357
PMCID:
PMC3345185
DOI:
10.1016/j.chembiol.2011.12.014
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center